Clinical Trial Update: Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated a basal insulin strategy using insulin detemir in combination with pre-meal insulin aspart to study effects on insulin secretion and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoLog (insulin aspart)

Snippet

Sponsor: University of Florida | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2016-07-29